Speakers

Paul Alloway

Vice President & Head of Legal
Foghorn Therapeutics (Cambridge, MA)

Greg Bell

Group Vice President and Life Sciences Practice Leader
Charles River Associates (Boston, MA)

Matt Blischak

Vice President, Intellectual Property Counsel
Roivant Sciences, Inc. (New York, NY)

Nicholas Boivin

Chief Intellectual Property Counsel
Forma Therapeutics (Watertown, MA)

Ralph W. Carmichael

Chairman & Chief Executive Officer
BŌNWRx Ltd. (Lansing, MI)

Catherine Eckenswiller

Legal Counsel – Intellectual Property & Agreements
VBI Vaccines Inc. (Ottawa, CA)

Jeffrey J. Ellison, Ph.D.

Partner
Clark + Elbing LLP (Boston, MA)

Alysia A. Finnegan, Ph.D., Esq.

Counsel, Intellectual Property Group
Merck & Co. Inc. (Rahway, NJ)

Geoffrey Taylor Gibbs

Deputy General Counsel, Business, Finance and Innovation
University of California, Office of the President (Oakland, CA)

Kimya Harris, Ph.D.

Vice President, Head of Intellectual Property and Legal Affairs
KSQ Therapeutics (Cambridge, MA)

Drew Holmes, Ph.D.

Senior Patent Attorney
Novartis Pharmaceuticals Corp. (East Hanover, NJ)

Thomas L. Irving

Partner
Finnegan Henderson Farabow Garrett & Dunner LLP (Washington, DC)

Brenda Jarrell, Ph.D.

Co-Chair of Intellectual Property and Life Sciences
Choate, Hall & Stewart LLP (Boston, MA)

Philip Johnson

Former Senior VP for IP Policy & Strategy
Johnson & Johnson (New Brunswick, NJ)

Mark D. Kafka

Associate Director, Assistant General Counsel
Genentech, Inc. (South San Francisco, CA)

Lacy Kolo, Ph.D.

Director, Tech and IP Advisory
Houlihan Lokey (McLean, VA)

John Krayacich

Vice-President & Head, Business Development & Licensing
Novartis Pharmaceuticals Corp. (East Hanover, NJ)

Examining the Due Diligence Inner Sanctum

November 29, 2018 11:15 am

Forrester J. Liddle Ph.D., J.D.

Director of Intellectual Property
Jounce Therapeutics (Cambridge, MA)

Jane M. Love, Ph.D.

Partner
Gibson, Dunn & Crutcher LLP (New York, NY)

Donna Meuth

Associate General Counsel – Intellectual Property
Eisai Inc. (Andover, MA)

The Honorable Paul R. Michel (Ret.)

Former Chief Judge
United States Court of Appeals for the Federal Circuit (Alexandria, VA)

Ahmed Mousa, J.D.

Vice President, Licensing, IP & Legal Affairs
Pieris Pharmaceuticals Inc. (Boston, MA)

Melanie R. Rupert

Partner, Life Sciences IP Litigation Global Co-Chair, Talent Development
Paul Hastings (New York, NY)

Jennifer Zarutskie Sieczkiewicz

Vice President, Chief Intellectual Property Counsel
Wave Life Sciences (Cambridge, MA)

Len Smith

Principal Counsel and Co-Founder
Transformative Legal (Scottsdale, AZ)

Gary J. Speier

Shareholder
Carlson Caspers Vandenburgh Lindquist & Schuman, PA (Minneapolis, MN)

Frederick K. Young, Ph.D.

Due Diligence Head CM and NS
Novartis Pharmaceuticals Corp. (East Hanover, NJ)

Examining the Due Diligence Inner Sanctum

November 29, 2018 11:15 am